We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$72.6B
AUM Growth
+$7.53B
Cap. Flow
+$3.73B
Cap. Flow %
5.13%
Top 10 Hldgs %
9.55%
Holding
3,940
New
507
Increased
1,441
Reduced
1,273
Closed
394

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$434M
2
NFLX icon
Netflix
NFLX
+$301M
3
BABA icon
Alibaba
BABA
+$245M
4
VZ icon
Verizon
VZ
+$235M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Technology 13.27%
2 Healthcare 11.28%
3 Consumer Discretionary 8.99%
4 Communication Services 8.03%
5 Industrials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNMK
3451
DELISTED
GenMark Diagnostics, Inc
GNMK
$94K ﹤0.01%
22,575
-70,504
-76% -$424K
CLSD
3452
DELISTED
Clearside Biomedical
CLSD
$92K ﹤0.01%
+875
New +$93.9K
STB
3453
DELISTED
Student Transportation Inc
STB
$91K ﹤0.01%
14,800
-5,800
-28% -$34.3K
ESV
3454
DELISTED
Ensco Rowan plc
ESV
$89K ﹤0.01%
3,762
-8,838
-70% -$196K
ONIT
3455
Onity Group
ONIT
$333M
$88K ﹤0.01%
1,870
+72
+4% +$3.61K
ARAV
3456
DELISTED
Aravive, Inc. Common Stock
ARAV
$87K ﹤0.01%
+6,555
New +$84.4K
ICL icon
3457
ICL Group
ICL
$6.81B
$86K ﹤0.01%
21,334
+5,773
+37% +$24K
INFN
3458
DELISTED
Infinera Corporation Common Stock
INFN
$86K ﹤0.01%
13,546
-11,016
-45% -$83.9K
ENT
3459
DELISTED
Global Eagle Entertainment Inc.
ENT
$86K ﹤0.01%
+1,487
New +$96.7K
CRBP icon
3460
Corbus Pharmaceuticals
CRBP
$170M
$84K ﹤0.01%
396
-25
-6% -$5.35K
GARS
3461
DELISTED
Garrison Capital Inc.
GARS
$84K ﹤0.01%
10,359
-10,597
-51% -$88.4K
UEC icon
3462
Uranium Energy
UEC
$4.71B
$83K ﹤0.01%
+46,865
New +$65.9K
TTOO
3463
DELISTED
T2 Biosystems, Inc
TTOO
$81K ﹤0.01%
+4
New +$82.6K
CFMS
3464
DELISTED
Conformis, Inc. Common Stock
CFMS
$81K ﹤0.01%
+1,353
New +$108K
GAU
3465
Galiano Gold
GAU
$486M
$80K ﹤0.01%
113,509
+5,700
+5% +$4.62K
KERX
3466
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$79K ﹤0.01%
16,921
-264,379
-94% -$1.46M
MCF
3467
DELISTED
Contango Oil & Gas Co.
MCF
$74K ﹤0.01%
15,684
-13,586
-46% -$52K
EXK
3468
Endeavour Silver
EXK
$2.32B
$73K ﹤0.01%
+30,654
New +$69.2K
HDSN
3469
Hudson Technologies
HDSN
$267M
$73K ﹤0.01%
11,953
-3,931
-25% -$23.9K
TAHO
3470
DELISTED
Tahoe Resources Inc
TAHO
$73K ﹤0.01%
+15,217
New +$71.6K
FLNA
3471
Filana Therapeutics
FLNA
$43M
$72K ﹤0.01%
17,957
-600
-3% -$2.42K
TNK icon
3472
Teekay Tankers
TNK
$2.63B
$72K ﹤0.01%
6,420
-4,623
-42% -$56.8K
MACQW
3473
DELISTED
M I Acquisitions, Inc. Warrant
MACQW
$72K ﹤0.01%
205,000
QHC
3474
DELISTED
Quorum Health Corporation
QHC
$67K ﹤0.01%
+10,718
New +$53.8K
SGYP
3475
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$65K ﹤0.01%
28,964
-6,385
-18% -$15.9K

Similar funds

D.E. Shaw & Co's Q4 2017 Portfolio in Review

As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $434M trimmed.

  • D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
  • D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
  • D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
  • D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
  • D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
  • D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.